World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
22217
World Ranking
3211
National Ranking
1271

Kyong-Mi Chang publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kyong-Mi Chang sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 155 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kyong-Mi Chang D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kyong-Mi Chang sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 59 D-Index — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Immune system

His primary areas of study are Immunology, Hepatitis C, Cytotoxic T cell, Virology and Hepatitis C virus. His research investigates the connection between Hepatitis C and topics such as Viral load that intersect with problems in Asymptomatic and Alpha interferon. His Virology study deals with CTL* intersecting with Chronic liver disease, Liver disease and NS3.

His work carried out in the field of Hepatitis C virus brings together such families of science as Gastroenterology and Internal medicine. Kyong-Mi Chang combines subjects such as Interferon and Viremia with his study of CD8. His Viremia study integrates concerns from other disciplines, such as Chronic infection and Hepatitis.

His most cited work include:

  • AASLD guidelines for treatment of chronic hepatitis B (1107 citations)
  • Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection (1064 citations)
  • Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection (1064 citations)

What are the main themes of his work throughout his whole career to date?

Kyong-Mi Chang mainly investigates Immunology, Internal medicine, Virology, Hepatitis C and Disease. His Immunology study frequently links to related topics such as Cytotoxic T cell. His biological study spans a wide range of topics, including T cell, CD8, Antigen, FOXP3 and Immunotherapy.

His Internal medicine study incorporates themes from Gastroenterology and Cardiology. Kyong-Mi Chang interconnects Epitope, CTL* and Immune system in the investigation of issues within Virology. His Hepatitis C study combines topics in areas such as Chronic liver disease, Cirrhosis, Veterans Affairs and Hepacivirus.

He most often published in these fields:

  • Immunology (61.67%)
  • Internal medicine (57.78%)
  • Virology (36.11%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (57.78%)
  • Disease (32.22%)
  • Coronary artery disease (16.67%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Disease, Coronary artery disease, Mendelian randomization and Genome-wide association study are his primary areas of study. He has included themes like Genetic variation and Cardiology in his Internal medicine study. His work deals with themes such as Genetics, Increased risk, Stroke and Single-nucleotide polymorphism, Genetic association, which intersect with Disease.

His work carried out in the field of Coronary artery disease brings together such families of science as Familial hypercholesterolemia, Type 2 diabetes, Apolipoprotein B and Risk factor. Kyong-Mi Chang interconnects Bioinformatics and Genetic architecture in the investigation of issues within Genome-wide association study. Acquired immune system is a primary field of his research addressed under Immunology.

Between 2018 and 2021, his most popular works were:

  • Multiplexed In Situ Imaging Mass Cytometry Analysis of the Human Endocrine Pancreas and Immune System in Type 1 Diabetes (62 citations)
  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)
  • Genome-wide association study of peripheral artery disease in the Million Veteran Program (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Immune system

His scientific interests lie mostly in Disease, Genome-wide association study, Internal medicine, Bioinformatics and Hepatitis B virus. The Disease study combines topics in areas such as Factor V Leiden, Biobank, Venous thromboembolism and Genome-Wide Association Analysis. The study incorporates disciplines such as Peripheral, LDL receptor, Migraine and Genetic architecture in addition to Genome-wide association study.

He has researched Internal medicine in several fields, including Apolipoprotein L1, Endocrinology and Risk allele. His Hepatitis B virus research is multidisciplinary, incorporating perspectives in Hepatitis B, Chronic infection and Hepatitis. His Hepatitis study deals with the bigger picture of Immunology.

Best Publications

  • Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

    Norah A. Terrault;Anna S.F. Lok;Brian J. McMahon;Kyong Mi Chang

  • AASLD guidelines for treatment of chronic hepatitis B

    Norah A. Terrault;Natalie H. Bzowej;Kyong Mi Chang;Jessica P. Hwang

  • Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

    Robert Thimme;David Oldach;Kyong Mi Chang;Kyong Mi Chang;Carola Steiger

  • Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria

    Gregory F. Sonnenberg;Laurel A. Monticelli;Theresa Alenghat;Thomas C. Fung

  • Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.

    Derek Klarin;Derek Klarin;Scott M Damrauer;Scott M Damrauer;Kelly Cho;Yan V Sun

  • Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.

    Kazushi Sugimoto;Fusao Ikeda;Jason Stadanlick;Frederick A. Nunes

  • Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

    Nobuhiro Nakamoto;Hyosun Cho;Hyosun Cho;Abraham Shaked;Kim Olthoff

  • Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection☆

    Kyong-Mi Chang;Kyong-Mi Chang;Robert Thimme;Jacqueline J. Melpolder;David Oldach

  • Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

    Kyong-Mi Chang;Barbara Rehermann;John G. McHutchison;Claudio Pasquinelli

  • Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

    B Rehermann;K M Chang;J G McHutchison;R Kokka

  • Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization

    Nobuhiro Nakamoto;Nobuhiro Nakamoto;David E. Kaplan;David E. Kaplan;Jennifer Coleclough;Jennifer Coleclough;Yun Li;Yun Li

  • Present and future therapies of hepatitis B: From discovery to cure

    T. Jake Liang;Timothy M. Block;Brian J. McMahon;Marc G. Ghany

  • Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.

    B Rehermann;K M Chang;J McHutchinson;R Kokka

  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

    Markus Cornberg;Anna Suk Fong Lok;Norah A. Terrault;Fabien Zoulim

  • Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells

    Bertram Bengsch;Takuya Ohtani;Omar Khan;Manu Setty

  • A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.

    David Gardiner;Jay Lalezari;Eric Lawitz;Michael DiMicco

  • Genome-wide association study of peripheral artery disease in the Million Veteran Program

    Derek Klarin;Julie Lynch;Julie Lynch;Krishna Aragam;Krishna Aragam;Mark Chaffin

  • Different affinity windows for virus and cancer-specific T-cell receptors – implications for therapeutic strategies

    Milos Aleksic;Nathaniel Liddy;Peter E. Molloy;Nick Pumphrey

  • Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis B

    Jang June Park;Jang June Park;David K. Wong;Abdus S. Wahed;William M. Lee

  • Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies

    Huaying Fang;Huaying Fang;Qin Hui;Qin Hui;Julie Lynch;Julie Lynch;Jacqueline Honerlaw

  • Hepatitis C virus: virology and life cycle.

    Chang Wook Kim;Kyong Mi Chang

  • PRACTICE GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B

    Norah A. Terrault;Natalie H. Bzowej;Kyong-Mi Chang;Jessica P. Hwang

Frequent Co-Authors

Philip S. Tsao
Philip S. Tsao Stanford University
Themistocles L. Assimes
Themistocles L. Assimes Stanford University
Christopher J. O'Donnell
Christopher J. O'Donnell Harvard Medical School
Daniel J. Rader
Daniel J. Rader University of Pennsylvania
Peter W.F. Wilson
Peter W.F. Wilson Emory University
J. Michael Gaziano
J. Michael Gaziano Brigham and Women's Hospital
Sekar Kathiresan
Sekar Kathiresan Harvard University
Danish Saleheen
Danish Saleheen Columbia University
Benjamin F. Voight
Benjamin F. Voight University of Pennsylvania
Norah A. Terrault
Norah A. Terrault University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to various healthcare and scientific careers, but many students also consider related fields like healthcare information management. For those interested in merging science with data, exploring a healthcare information management salary can give insight into the financial benefits and growth opportunities in this sector.

If you're leaning towards advancing your career through education, pursuing an online cahiim accredited health information management degree can be a convenient and reputable option. This pathway often leads to roles that combine healthcare knowledge with information technology expertise.

For quicker entry into the healthcare field, consider an medical billing and coding certificate online accelerated program. These certificates can be completed swiftly, enabling graduates to fill essential administrative roles within healthcare settings.

Additionally, many students look at online healthcare degrees that pay well to balance flexibility with competitive salaries. Exploring these options alongside microbiology can provide a well-rounded approach to a rewarding career in health sciences.

Best Scientists Citing Kyong-Mi Chang

Trending Scientists

Recently Published Articles